This document details the administered, departmental and total funding amounts for capped costings included in Appendix C, Table C-1 of the 2019 Post-election report.

The Commonwealth Government would provide dedicated funding to state and territory governments to fund the dispensing fees for all patients receiving opioid dependence treatment (methadone, buprenorphine and buprenorphine‐naloxone) and any associated administration costs.

The dispensing fee funding would be a standardised amount paid by states and territories to dosing point sites (mostly community pharmacies) for each dose of opioid dependence treatment.

The Commonwealth Government would provide dedicated funding to state and territory governments to fund the dispensing fees for all patients receiving opioid dependence treatment (methadone, buprenorphine and buprenorphine‐naloxone) and any associated administration costs.

The dispensing fee funding would be a standardised amount paid by states and territories to dosing point sites (mostly community pharmacies) for each dose of opioid dependence treatment.

The Commonwealth Government would provide dedicated funding to state and territory governments to fund the dispensing fees for all patients receiving opioid dependence treatment (methadone, buprenorphine and buprenorphine‐naloxone) and any associated administration costs.

The dispensing fee funding would be a standardised amount paid by states and territories to dosing point sites (mostly community pharmacies) for each dose of opioid dependence treatment.

The Commonwealth Government would provide dedicated funding to state and territory governments to fund the dispensing fees for all patients receiving opioid dependence treatment (methadone, buprenorphine and buprenorphine‐naloxone) and any associated administration costs.

The dispensing fee funding would be a standardised amount paid by states and territories to dosing point sites (mostly community pharmacies) for each dose of opioid dependence treatment.

This proposal would establish a new agency, the National Preventative Health Commission (the
Commission). The Commission would play a role in preventative and public health policy oversight,
provide advice to the Commonwealth Government, and undertake health promotion, including
through offering grants for health promotion initiatives.

The funding for the Commission would be equal to the sum of funding for the Victorian Health
Promotion Foundation (VicHealth) and the former Australian National Preventive Health Agency.

This proposal consists of two components.

Component 1 – Re-instate indexation

This proposal consists of two components.

Component 1 – Re-instate indexation

The proposal would provide one‐off payments to the states and territories (the states) to help
eliminate public hospital surgery waiting lists for particular categories of clinical urgency. These
payments would be spread over two years from 1 July 2019, with 80 per cent paid in the first year.

The payment would be based on the number of patients on elective surgery waiting lists who have
been waiting longer than clinically indicated for their category as at 30 June 2019. All patients in
clinical urgency categories 1, 2 and 3 would be eligible.

The proposal would provide one‐off payments to the states and territories (the states) to help
eliminate public hospital surgery waiting lists for particular categories of clinical urgency. These
payments would be spread over two years from 1 July 2019, with 80 per cent paid in the first year.

The payment would be based on the number of patients on elective surgery waiting lists who have
been waiting longer than clinically indicated for their category as at 30 June 2019. All patients in
clinical urgency categories 1, 2 and 3 would be eligible.